Another new clinical trial started in 2021 in Texas, USA (NCT04991870).183 It aims to recruit 25 participants with recurrent supratentorial GBM who will be subjected to a treatment regimen consisting of the intratumoral administration of allogeneic umbilical cord blood NK cells wi...
Accessed September 19, 2021. 66. Reardon DA, Kim TM, Frenel JS, et al. Treatment with pembrolizumab in programmed death ligand 1-positive recurrent glioblastoma: results from the multicohort Phase 1 KEYNOTE-028 trial. Cancer. 2021;127(10):1620–1629. doi:10.1002/cncr.33378 67. Therasse ...